These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32103957)

  • 1. Adjunctive Rufinamide in Children with Lennox-Gastaut Syndrome: A Literature Review.
    Balagura G; Riva A; Marchese F; Verrotti A; Striano P
    Neuropsychiatr Dis Treat; 2020; 16():369-379. PubMed ID: 32103957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating Lennox-Gastaut syndrome in epileptic pediatric patients with third-generation rufinamide.
    Gresham J; Eiland LS; Chung AM
    Neuropsychiatr Dis Treat; 2010 Oct; 6():639-45. PubMed ID: 20957124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of rufinamide as adjunctive therapy in patients with Lennox Gastaut syndrome: A systematic review and Meta-analysis.
    Sharawat IK; Panda PK; Panda P; Dawman L
    Seizure; 2021 Oct; 91():296-307. PubMed ID: 34273668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of rufinamide in children and adults with Lennox-Gastaut syndrome: A post hoc analysis from Study 022.
    Arzimanoglou A; Pringsheim M; Kluger GJ; Genton P; Perdomo C; Malhotra M
    Epilepsy Behav; 2021 Sep; 124():108275. PubMed ID: 34509883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of rufinamide in the management of Lennox-Gastaut syndrome (childhood epileptic encephalopathy).
    Kluger G; Bauer B
    Neuropsychiatr Dis Treat; 2007 Feb; 3(1):3-11. PubMed ID: 19300535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines.
    Coppola G; Besag F; Cusmai R; Dulac O; Kluger G; Moavero R; Nabbout R; Nikanorova M; Pisani F; Verrotti A; von Stülpnagel C; Curatolo P
    Eur J Paediatr Neurol; 2014 Nov; 18(6):685-90. PubMed ID: 24929673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on rufinamide in childhood epilepsy.
    Coppola G
    Neuropsychiatr Dis Treat; 2011; 7():399-407. PubMed ID: 21792306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rufinamide for the treatment of Lennox-Gastaut syndrome: evidence from clinical trials and clinical practice.
    Striano P; McMurray R; Santamarina E; Falip M
    Epileptic Disord; 2018 Feb; 20(1):13-29. PubMed ID: 29313492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rufinamide: a pharmacoeconomic profile of its use as adjunctive therapy in Lennox-Gastaut syndrome.
    McCormack PL
    Pharmacoeconomics; 2012 Mar; 30(3):247-56. PubMed ID: 22332960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rufinamide for the treatment of Lennox-Gastaut syndrome.
    Besag FM
    Expert Opin Pharmacother; 2011 Apr; 12(5):801-6. PubMed ID: 21348771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rufinamide as an adjunctive therapy for Lennox-Gastaut syndrome: a randomized double-blind placebo-controlled trial in Japan.
    Ohtsuka Y; Yoshinaga H; Shirasaka Y; Takayama R; Takano H; Iyoda K
    Epilepsy Res; 2014 Nov; 108(9):1627-36. PubMed ID: 25219353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world data on rufinamide treatment in patients with Lennox-Gastaut syndrome: Results from a European noninterventional registry study.
    Nikanorova M; Brandt C; Auvin S; McMurray R
    Epilepsy Behav; 2017 Nov; 76():63-70. PubMed ID: 28927712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacological management of Lennox-Gastaut syndrome and critical literature review.
    Verrotti A; Striano P; Iapadre G; Zagaroli L; Bonanni P; Coppola G; Elia M; Mecarelli O; Franzoni E; Liso P; Vigevano F; Curatolo P
    Seizure; 2018 Dec; 63():17-25. PubMed ID: 30391662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rufinamide efficacy and safety in children aged 1-4 years with Lennox-Gastaut syndrome.
    Kim SH; Kang HC; Lee JS; Kim HD
    Brain Dev; 2018 Nov; 40(10):897-903. PubMed ID: 30166208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposed anti-seizure medication combinations with rufinamide in the treatment of Lennox-Gastaut syndrome: Narrative review and expert opinion.
    Sankar R; Chez M; Pina-Garza JE; Dixon-Salazar T; Flamini JR; Hyslop A; McGoldrick P; Millichap JJ; Resnick T; Rho JM; Wolf S
    Seizure; 2023 Aug; 110():42-57. PubMed ID: 37321047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Adults with Lennox-Gastaut Syndrome: Further Analysis of Efficacy and Safety/Tolerability of Rufinamide.
    McMurray R; Striano P
    Neurol Ther; 2016 Jun; 5(1):35-43. PubMed ID: 26861566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the management of Lennox-Gastaut syndrome with a focus on rufinamide.
    Stafstrom CE
    Neuropsychiatr Dis Treat; 2009; 5():547-51. PubMed ID: 19898669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rufinamide: a new antiepileptic medication for the treatment of seizures associated with lennox-gastaut syndrome.
    Wisniewski CS
    Ann Pharmacother; 2010 Apr; 44(4):658-67. PubMed ID: 20233912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosing considerations for rufinamide in patients with Lennox-Gastaut syndrome: Phase III trial results and real-world clinical data.
    Kothare S; Kluger G; Sachdeo R; Williams B; Olhaye O; Perdomo C; Bibbiani F
    Seizure; 2017 Apr; 47():25-33. PubMed ID: 28284045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Short-term efficacy and safety of rufinamide for Lennox-Gastaut syndrome].
    Takayama R; Fukumura S; Minagawa K; Watanabe T
    No To Hattatsu; 2016 Sep; 48(5):322-6. PubMed ID: 30010275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.